393 related articles for article (PubMed ID: 16844713)
21. Effective network of deep brain stimulation of subthalamic nucleus with bimodal positron emission tomography/functional magnetic resonance imaging in Parkinson's disease.
Chen HM; Sha ZQ; Ma HZ; He Y; Feng T
CNS Neurosci Ther; 2018 Feb; 24(2):135-143. PubMed ID: 29222835
[TBL] [Abstract][Full Text] [Related]
22. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
[TBL] [Abstract][Full Text] [Related]
23. Metabolic correlates of levodopa response in Parkinson's disease.
Feigin A; Fukuda M; Dhawan V; Przedborski S; Jackson-Lewis V; Mentis MJ; Moeller JR; Eidelberg D
Neurology; 2001 Dec; 57(11):2083-8. PubMed ID: 11739830
[TBL] [Abstract][Full Text] [Related]
24. Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait.
Lyoo CH; Aalto S; Rinne JO; Lee KO; Oh SH; Chang JW; Lee MS
Mov Disord; 2007 Nov; 22(15):2176-82. PubMed ID: 17712844
[TBL] [Abstract][Full Text] [Related]
25. Deep brain stimulation induced normalization of the human functional connectome in Parkinson's disease.
Horn A; Wenzel G; Irmen F; Huebl J; Li N; Neumann WJ; Krause P; Bohner G; Scheel M; Kühn AA
Brain; 2019 Oct; 142(10):3129-3143. PubMed ID: 31412106
[TBL] [Abstract][Full Text] [Related]
26. Effects of STN-DBS surgery on cerebral glucose metabolism and distribution of DAT in Parkinson's disease.
Luo G; Shi X; Jiang L; Wu L; Yi C; Xian W; Liu Y; Wen F; Qian H; Chen J; Fu X; Liu J; Zhang X; Chen L
Brain Behav; 2023 Aug; 13(8):e3172. PubMed ID: 37459244
[TBL] [Abstract][Full Text] [Related]
27. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease.
Herzog J; Weiss PH; Assmus A; Wefer B; Seif C; Braun PM; Herzog H; Volkmann J; Deuschl G; Fink GR
Brain; 2006 Dec; 129(Pt 12):3366-75. PubMed ID: 17077105
[TBL] [Abstract][Full Text] [Related]
28. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.
Ma Y; Tang C; Spetsieris PG; Dhawan V; Eidelberg D
J Cereb Blood Flow Metab; 2007 Mar; 27(3):597-605. PubMed ID: 16804550
[TBL] [Abstract][Full Text] [Related]
29. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
[TBL] [Abstract][Full Text] [Related]
30. Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease.
Haslinger B; Kalteis K; Boecker H; Alesch F; Ceballos-Baumann AO
Neuroimage; 2005 Nov; 28(3):598-606. PubMed ID: 16081302
[TBL] [Abstract][Full Text] [Related]
31. Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.
Smith GS; Mills KA; Pontone GM; Anderson WS; Perepezko KM; Brasic J; Zhou Y; Brandt J; Butson CR; Holt DP; Mathews WB; Dannals RF; Wong DF; Mari Z
Parkinsonism Relat Disord; 2019 Jul; 64():235-241. PubMed ID: 31053531
[TBL] [Abstract][Full Text] [Related]
32. A network analysis of ¹⁵O-H₂O PET reveals deep brain stimulation effects on brain network of Parkinson's disease.
Park HJ; Park B; Kim HY; Oh MK; Kim JI; Yoon M; Lee JD; Chang JW
Yonsei Med J; 2015 May; 56(3):726-36. PubMed ID: 25837179
[TBL] [Abstract][Full Text] [Related]
33. Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation.
Mure H; Tang CC; Argyelan M; Ghilardi MF; Kaplitt MG; Dhawan V; Eidelberg D
J Neurosci; 2012 Feb; 32(8):2804-13. PubMed ID: 22357863
[TBL] [Abstract][Full Text] [Related]
34. Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: a 4-year follow-up study with rCBF SPECT.
Sestini S; Ramat S; Formiconi AR; Ammannati F; Sorbi S; Pupi A
J Nucl Med; 2005 Sep; 46(9):1444-54. PubMed ID: 16157526
[TBL] [Abstract][Full Text] [Related]
35. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
[TBL] [Abstract][Full Text] [Related]
36. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
[TBL] [Abstract][Full Text] [Related]
37. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
[TBL] [Abstract][Full Text] [Related]
38. Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.
Hirano S; Asanuma K; Ma Y; Tang C; Feigin A; Dhawan V; Carbon M; Eidelberg D
J Neurosci; 2008 Apr; 28(16):4201-9. PubMed ID: 18417699
[TBL] [Abstract][Full Text] [Related]
39. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
[TBL] [Abstract][Full Text] [Related]
40. Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation?
Marques A; Fantini ML; Morand D; Pereira B; Derost P; Ulla M; Debilly B; Lemaire JJ; Durif F
Sleep Med; 2015 May; 16(5):583-8. PubMed ID: 25881920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
